A radiology AI flags a chest X-ray as normal. The radiologist agrees — the AI confirmed their read. Six weeks later, the patient presents with stage III lung cancer clearly visible on the original image. The AI missed it. The radiologist trusted it. The patient is now in treatment that could have started six weeks earlier.
Who investigates this? Your patient safety officer? Your IT department? Your vendor?
The answer at most community health organizations is: nobody, because no one has a plan for this.
AI Incidents Don't Look Like Traditional Patient Safety Events
Patient safety programs are built around a familiar model. A clinician makes a decision. Something goes wrong. You investigate the decision, the context, and the system conditions. Root cause analysis has been standard practice for decades.
AI breaks this model. There is no single decision point. A clinical AI failure involves at least five layers, any of which — or any combination of which — can be the source:
- Model failure — the algorithm itself produces an incorrect output. The radiology AI misses the lesion. The sepsis predictor generates a false negative.
- Integration failure — the model works correctly in isolation but fails when embedded in clinical workflow. Alerts fire at the wrong time, display in the wrong context, or route to the wrong provider.
- Workflow failure — the model and integration work, but the clinical process around them doesn't account for AI limitations. No one is assigned to act on the output. Override protocols don't exist.
- Human-AI interaction failure — clinicians over-trust or under-trust the model. After 50 consecutive false positive deterioration alerts, the 51st — the real one — gets ignored. Automation bias is not a character flaw. It's a predictable system failure.
- Data quality failure — the model was trained on data that doesn't represent your patient population, or your local data feed is stale, incomplete, or miscoded. The algorithm is doing exactly what it was trained to do. It was trained on the wrong inputs.
Traditional root cause analysis asks: what happened, and why? AI incident investigation asks: what happened, where in the stack did it happen, who owns that layer, and what does the vendor contract say about it?
Most patient safety programs are not equipped for that question.
The Incidents Already Happening
These are not hypotheticals. Documentation AI is fabricating medication names in clinical notes — plausible-sounding drugs that don't exist, inserted into visit summaries that clinicians sign without reading line by line because they reviewed 40 notes that day. Deterioration prediction models are crying wolf at rates that make the real alerts invisible. Diagnostic support tools trained on academic medical center data are performing differently in safety-net populations with different comorbidity profiles and documentation patterns.
The common thread: none of these surface through traditional incident reporting. A fabricated medication in a note doesn't trigger an adverse event report unless someone catches it and a prescription gets filled. A missed deterioration alert doesn't get reported because the alert system is already considered unreliable. A diagnostic miss attributed to AI gets coded as a clinical judgment issue.
AI incidents hide inside existing categories. That's what makes them dangerous.
What an AI Incident Response Plan Actually Contains
If your organization deploys clinical AI — even something as simple as ambient documentation or a clinical decision support tool — you need a response framework built for the failure modes described above. Here's what that contains:
An AI incident taxonomy. Define what counts as an AI incident at your organization. Not every incorrect AI output is an incident — but you need criteria for when it becomes one. Severity tiers. Reporting thresholds. Clear distinction between adverse events and near-misses.
An investigation methodology adapted for AI. Standard RCA doesn't work when the "root cause" might be a training dataset assembled by a vendor two years ago. Your methodology needs to trace failures across the model, integration, workflow, interaction, and data layers. It needs to distinguish between problems you can fix locally and problems that require vendor action.
Defined vendor accountability. When the model is wrong, what does your vendor owe you? Access to model performance data? Retraining timelines? Disclosure of known limitations? If your vendor contract doesn't specify incident response obligations, you have no leverage when something breaks. And something will break.
Near-miss tracking. This is where most organizations have the biggest gap. AI near-misses — the false positive caught before it caused harm, the fabricated medication noticed before it was prescribed, the incorrect risk score overridden by a clinician who knew better — are the leading indicators of future adverse events. If you're not tracking them, you're waiting for the adverse event to learn what your AI systems are doing wrong.
Disclosure obligations. When an AI-involved adverse event occurs, what are your disclosure obligations to the patient? To your board? To CMS? The regulatory landscape is evolving fast, but "we didn't know the AI was involved" is not a defensible position. Your incident response plan needs to address how AI involvement in adverse events gets documented and disclosed.
Post-incident improvement. Investigation without action is documentation theater. Your plan needs to specify what changes after an incident: model reconfiguration, workflow redesign, vendor escalation, clinician retraining, or — when warranted — decommissioning the tool.
Why Most Health Centers Don't Have One
Three reasons.
First, vendor marketing doesn't mention failure modes. The sales process for clinical AI is heavy on accuracy metrics and light on what happens when the accuracy doesn't hold. Vendors show you sensitivity and specificity numbers from validation studies. They don't hand you an incident response template.
Second, patient safety and IT don't talk to each other about this. Patient safety owns adverse event investigation. IT owns the AI tools. Neither team has the full picture. The patient safety team doesn't understand the technology stack well enough to investigate AI failures. The IT team doesn't understand clinical workflow well enough to recognize when a technical problem becomes a patient safety problem.
Third, the regulatory framework is still catching up. ONC, CMS, and the FDA are all moving on AI oversight, but community health organizations — FQHCs, critical access hospitals, tribal health programs — are largely left to build their own governance frameworks. The large health systems have dedicated AI governance committees. Safety-net providers are deploying the same tools with a fraction of the infrastructure.
The Gap Between Deployment and Governance
Here's the uncomfortable reality: AI tools are already in your workflows. Ambient documentation. Clinical decision support. Revenue cycle automation. Predictive analytics. Some were procured through formal channels. Some showed up inside an EHR update. Some a clinician started using on their own.
The question is not whether you need an AI incident response plan. The question is whether you'll build one before or after the first serious failure.
Community health organizations serve populations where the margin for error is smallest and the safety net beneath the safety net doesn't exist. An AI failure at an academic medical center becomes a case study. An AI failure at a rural critical access hospital or tribal health clinic becomes a patient who doesn't come back.
Start With the Assessment
You don't need a 50-page AI governance manual to start. You need to know where you stand: what AI tools are deployed, what oversight exists, where the gaps are, and what to build first.
Take the AI governance readiness assessment to identify your organization's incident response gaps — before an incident identifies them for you.
LumenHealth provides AI governance assessments and readiness tools for community health organizations. This article is for informational purposes and does not constitute legal, clinical, or compliance advice.
Assess your organization's AI governance readiness
37 questions across five domains. Free facilitated debrief with your leadership team.